Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients: An Observational Study

NCT04669574 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04669574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients: An Observational Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
June 29, 2021
Completion date
December 9, 2024
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronodisruption, sleep circadian rhythms